Zhentong Wei

Xinmin Road 519
Changchun, 130001, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Correction: the promoting effect and mechanism of Nrf2 on cell metastasis in cervical cancer.

Correction: the promoting effect and mechanism of Nrf2 on cell metastasis in cervical cancer.

Journal: Journal of translational medicine

Published: December 03, 2025

Fully synthetic nanofibrillar hydrogel for the growth and enzyme-free release of patient-derived ovarian tumor organoids.

Fully synthetic nanofibrillar hydrogel for the growth and enzyme-free release of patient-derived ovarian tumor organoids.

Journal: Biomaterials

Published: July 09, 2025

Single-cell and spatial transcriptomic profiling reveals distinct tumor microenvironment dynamics in cervical adenocarcinoma and squamous cell carcinoma.

Single-cell and spatial transcriptomic profiling reveals distinct tumor microenvironment dynamics in cervical adenocarcinoma and squamous cell carcinoma.

Journal: Communications biology

Published: April 21, 2025

Tiliroside induces ferroptosis and suppresses tumor growth by synergistically targeting AKR1B1 and modulating iron metabolism in ovarian cancer cells.

Tiliroside induces ferroptosis and suppresses tumor growth by synergistically targeting AKR1B1 and modulating iron metabolism in ovarian cancer cells.

Journal: European journal of pharmacology

Published: February 17, 2025

Daphnetin induces ferroptosis in ovarian cancer by inhibiting NAD(P)H:Quinone oxidoreductase 1 (NQO1).

Daphnetin induces ferroptosis in ovarian cancer by inhibiting NAD(P)H:Quinone oxidoreductase 1 (NQO1).

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: February 25, 2024

Screening by Q Exactive liquid chromatography/tandem mass spectrometry identified Choline, 25-hydroxyvitamin D2, and SM(d18:0/16:1(9Z) (OH)) as biomarkers for high-grade serous ovarian cancer.

Screening by Q Exactive liquid chromatography/tandem mass spectrometry identified Choline, 25-hydroxyvitamin D2, and SM(d18:0/16:1(9Z) (OH)) as biomarkers for high-grade serous ovarian cancer.

Journal: Journal of proteomics

Published: July 16, 2023

Identification of metabolic biomarkers for diagnosis of epithelial ovarian cancer using internal extraction electrospray ionization mass spectrometry (iEESI-MS).

Identification of metabolic biomarkers for diagnosis of epithelial ovarian cancer using internal extraction electrospray ionization mass spectrometry (iEESI-MS).

Journal: Cancer biomarkers : section A of Disease markers

Published: May 30, 2023

The promoting effect and mechanism of Nrf2 on cell metastasis in cervical cancer.

The promoting effect and mechanism of Nrf2 on cell metastasis in cervical cancer.

Journal: Journal of translational medicine

Published: May 03, 2023

Prevalence of sexual dysfunction among the male populations who seeking medical care for infertility, pregnancy loss and preconception care: a cross-sectional study.

Prevalence of sexual dysfunction among the male populations who seeking medical care for infertility, pregnancy loss and preconception care: a cross-sectional study.

Journal: Scientific reports

Published: March 21, 2022

Instructive Hydrogels for Primary Tumor Cell Culture: Current Status and Outlook.

Instructive Hydrogels for Primary Tumor Cell Culture: Current Status and Outlook.

Journal: Advanced healthcare materials

Published: November 13, 2021

Nrf2 Signaling Pathway Mediates the Protective Effects of Daphnetin Against D-Galactose Induced-Premature Ovarian Failure.

Nrf2 Signaling Pathway Mediates the Protective Effects of Daphnetin Against D-Galactose Induced-Premature Ovarian Failure.

Journal: Frontiers in pharmacology

Published: November 07, 2021

High expression level of CXCL1/GROα is linked to advanced stage and worse survival in uterine cervical cancer and facilitates tumor cell malignant processes.

High expression level of CXCL1/GROα is linked to advanced stage and worse survival in uterine cervical cancer and facilitates tumor cell malignant processes.

Journal: BMC cancer

Published: October 09, 2021

Showing 1-12 of 29

Last Updated: 09/26/2026